Word

CONFLUX SYNTHESIS

Status

Pending

Status Code

732

Status Date

Monday, March 4, 2024

Serial Number

90878963

Mark Type

4000

Filing Date

Thursday, August 12, 2021

Published for Opposition

Tuesday, July 12, 2022

Trademark Owner History

ABIOLOGICS, INC. - 1st New Owner After Publication
Flagship Labs 83, Inc. - Owner At Publication

Classifications

5 protein arrays for medical diagnosis purposes; pharmaceutical preparations for use in the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders; therapeutic pharmaceuticals for the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders

1 proteins for use in manufacture; proteins for industrial use in agriculture, aquaculture, cosmetics, consumer products and nutrition products

42 scientific research, pharmaceutical research, medical research; biotechnology research; technical scientific consultation and product development for others in the field of biotechnology and the development of protein-based pharmaceuticals, diagnostics, biomaterials, industrial reagents, agricultural products, cosmetics, consumer products and nutrition products

"SYNTHESIS"

Trademark Events

Mar 5, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 4, 2024

Sou Extension 3 Granted

Mar 4, 2024

Sou Extension 3 Filed

Mar 4, 2024

Sou Teas Extension Received

Jan 12, 2024

Assigned To Examiner

Aug 31, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 29, 2023

Sou Extension 2 Granted

Aug 29, 2023

Sou Extension 2 Filed

Aug 29, 2023

Sou Teas Extension Received

Mar 1, 2023

Notice Of Approval Of Extension Request E-Mailed

Feb 27, 2023

Sou Extension 1 Granted

Feb 27, 2023

Sou Extension 1 Filed

Feb 27, 2023

Sou Teas Extension Received

Feb 22, 2023

Automatic Update Of Assignment Of Ownership

Sep 6, 2022

Noa E-Mailed - Sou Required From Applicant

Jul 12, 2022

Official Gazette Publication Confirmation E-Mailed

Jul 12, 2022

Published For Opposition

Jun 22, 2022

Notification Of Notice Of Publication E-Mailed

Jun 9, 2022

Approved For Pub - Principal Register

Jun 8, 2022

Data Modification Completed

Jun 8, 2022

Assigned To Lie

Jun 7, 2022

Teas/Email Correspondence Entered

Jun 6, 2022

Correspondence Received In Law Office

Jun 6, 2022

Teas Response To Office Action Received

May 18, 2022

Notification Of Non-Final Action E-Mailed

May 18, 2022

Non-Final Action E-Mailed

May 18, 2022

Non-Final Action Written

May 13, 2022

Assigned To Examiner

Oct 3, 2021

New Application Office Supplied Data Entered